The Florida Department of Health is seeking applications for its 2024-2025 James and Esther King Biomedical Research Grant Program.
Donor Name: Florida Department of Health
State: Florida
County: All Counties
Type of Grant: Grant
Deadline: 08/29/2024
Size of the Grant: Not Available
Grant Duration: Grant Duration Not Mentioned
Details:
The James and Esther King Biomedical Research Program (James and Esther King Program) is established in section 215.5602, Florida Statutes. The purpose of the program is to support research initiatives that address the healthcare problems of Floridians in the areas of tobacco-related cancer, cardiovascular disease, stroke, and pulmonary disease, by pursuing the following goals:
- Improve the health of Floridians by researching better prevention, diagnoses, treatments, and cures for cancer, cardiovascular disease, stroke, and pulmonary disease.
- Expand the foundation of biomedical knowledge relating to the prevention, diagnosis, treatment, and cure of diseases related to tobacco use, including cancer, cardiovascular disease, stroke, and pulmonary disease.
- Improve the quality of the state’s academic health centers by bringing the advances of biomedical research into the training of physicians and other health care providers.
- Increase the state’s per capita funding for research by undertaking new initiatives in public health and biomedical research that will attract additional funding from outside the state.
- Stimulate economic activity in the state in areas related to biomedical research, such as the research and production of pharmaceuticals, biotechnology, and medical devices.
Research Priorities
- The Biomedical Research Advisory Council (BRAC) advises the State Surgeon General as to the direction and scope of grant programs. The responsibilities of the council may include, but are not limited to:
- Providing advice on Program priorities and emphases.
- Developing criteria and standards for the award of research grants.
- To balance the number of grants awarded across Research Priorities, this year the Department will prioritize applications that address the following:
- Reduction of mortality and morbidity as related to disproportionately impacted individuals.
- Improve screening accuracy and detection in high-risk groups.
- Resistance to front-line treatments in recurrent disease in the five cancers listed.
- Research focused on sarcomas, or leukemia and other blood cancers.
- Prevention and treatment research evaluating programs for tobacco use reduction and prevention (James & Esther King Program).
- Research focused on the biologic mechanisms of use of electronic cigarettes, transition from combustible tobacco to electronic cigarettes, relationship between electronic cigarette use and different cancers, effects of electronic cigarette use in individuals treated for cancer, and intervention to reduce or prevent electronic cigarette use. (James and Esther King Program).
- Examine the relationship between obesity and cancer, cancer treatment responsiveness, and cancer treatment-related morbidities. Applications related to other areas described in the FOA will be considered, but not at the same level of priority.
Eligibility Criteria
- According to sections 215.5602(5) (a) and 381.922(3) (a), Florida Statutes, applications for biomedical research funding may be submitted from any university or established research institute in Florida.
- Each application must identify a Corresponding Principal Investigator. The Corresponding Principal Investigator is the individual designated by the applicant organization legally responsible to direct the grant project. The Corresponding Principal Investigator is responsible and accountable to the applicant organization officials for the project’s scientific and technical direction as well as the proper conduct of the project. There must be one designated Corresponding Principal Investigator. There may be multiple Principal Investigators on a project, but there must be only one Corresponding Principal Investigator.
For more information, visit DOH.
